Cargando…

Bioengineering in the oral cavity: our experience

BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalfamo, L, Belli, E, Nava, C, Mici, E, Calvo, A, D’Alessandro, B, De Ponte, FS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797608/
https://www.ncbi.nlm.nih.gov/pubmed/24143092
http://dx.doi.org/10.2147/IJN.S47697
_version_ 1782287636789985280
author Catalfamo, L
Belli, E
Nava, C
Mici, E
Calvo, A
D’Alessandro, B
De Ponte, FS
author_facet Catalfamo, L
Belli, E
Nava, C
Mici, E
Calvo, A
D’Alessandro, B
De Ponte, FS
author_sort Catalfamo, L
collection PubMed
description BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. METHODS: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. RESULTS: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. CONCLUSION: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery.
format Online
Article
Text
id pubmed-3797608
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37976082013-10-18 Bioengineering in the oral cavity: our experience Catalfamo, L Belli, E Nava, C Mici, E Calvo, A D’Alessandro, B De Ponte, FS Int J Nanomedicine Original Research BACKGROUND: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. METHODS: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. RESULTS: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. CONCLUSION: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Dove Medical Press 2013 2013-10-09 /pmc/articles/PMC3797608/ /pubmed/24143092 http://dx.doi.org/10.2147/IJN.S47697 Text en © 2013 Catafalmo et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Catalfamo, L
Belli, E
Nava, C
Mici, E
Calvo, A
D’Alessandro, B
De Ponte, FS
Bioengineering in the oral cavity: our experience
title Bioengineering in the oral cavity: our experience
title_full Bioengineering in the oral cavity: our experience
title_fullStr Bioengineering in the oral cavity: our experience
title_full_unstemmed Bioengineering in the oral cavity: our experience
title_short Bioengineering in the oral cavity: our experience
title_sort bioengineering in the oral cavity: our experience
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797608/
https://www.ncbi.nlm.nih.gov/pubmed/24143092
http://dx.doi.org/10.2147/IJN.S47697
work_keys_str_mv AT catalfamol bioengineeringintheoralcavityourexperience
AT bellie bioengineeringintheoralcavityourexperience
AT navac bioengineeringintheoralcavityourexperience
AT micie bioengineeringintheoralcavityourexperience
AT calvoa bioengineeringintheoralcavityourexperience
AT dalessandrob bioengineeringintheoralcavityourexperience
AT depontefs bioengineeringintheoralcavityourexperience